How many institutions held VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share in Q2 2021?

49 institutional investors reported VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share for Q2 2021. Use the holders table for investor-level position and value details.

VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR)

Q: What does CUSIP 929033108 represent in this 13F holders report?

CUSIP 929033108 is the security identifier for VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 929033108

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 64,015,196
Total 13F shares: 30,740,152
Share change: +33,445
Total reported value: $570,752,000
Price per share: $18.65
Number of holders: 49
Value change: -$868,415
Number of buys: 22
Number of sells: 24

Quarterly Holders Quick Answers

What is CUSIP 929033108?
CUSIP 929033108 identifies VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 929033108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	17%	11,120,973	$479,314,000	—	31 Mar 2021	13F
5AM Venture Management, LLC	13F	Company	10%	6,692,429	$288,444,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	5.7%	3,677,048	$146,673,000	—	31 Mar 2021	13F
Woodline Partners LP	13F	Company	1.8%	1,153,267	$49,706,000	—	31 Mar 2021	13F
Johnson & Johnson Innovation - JJDC, Inc.	13F	Company	1.7%	1,074,658	$46,318,000	—	31 Mar 2021	13F
ORBIMED ADVISORS LLC	13F	Company	1.3%	833,333	$35,917,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	1.3%	806,562	$34,763,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	1.2%	767,816	$33,094,000	—	31 Mar 2021	13F
Sarissa Capital Management LP	13F	Company	1.1%	707,010	$30,472,000	—	31 Mar 2021	13F
Laurion Capital Management LP	13F	Company	0.91%	585,667	$25,242,000	—	31 Mar 2021	13F
Artal Group S.A.	13F	Company	0.86%	550,000	$23,705,000	—	31 Mar 2021	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.86%	550,000	$23,705,000	—	31 Mar 2021	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.84%	535,259	$23,070,000	—	31 Mar 2021	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.52%	331,515	$14,288,000	—	31 Mar 2021	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	0.43%	277,777	$11,972,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.29%	188,215	$8,112,000	—	31 Mar 2021	13F
Trustees of Columbia University in the City of New York	13F	Company	0.29%	183,821	$7,923,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.26%	169,531	$7,307,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.19%	121,954	$5,256,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	73,241	$3,157,000	—	31 Mar 2021	13F
Bollard Group LLC	13F	Company	0.09%	55,555	$2,394,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.06%	41,527	$1,790,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.05%	32,279	$1,391,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.05%	30,141	$1,300,000	—	31 Mar 2021	13F
Zweig-DiMenna Associates LLC	13F	Company	0.03%	20,000	$862,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	18,844	$813,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	17,211	$742,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	9,608	$414,000	—	31 Mar 2021	13F
Qube Research & Technologies Ltd	13F	Company	0.01%	9,065	$391,000	—	31 Mar 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	8,600	$371,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	7,505	$324,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	0.01%	7,093	$306,000	—	31 Mar 2021	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	6,650	$287,000	—	31 Mar 2021	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	6,427	$277,000	—	31 Mar 2021	13F
MetLife Investment Management, LLC	13F	Company	0.01%	5,523	$238,041	—	31 Mar 2021	13F
ExodusPoint Capital Management, LP	13F	Company	0.01%	5,028	$217,000	—	31 Mar 2021	13F
Pinz Capital Management, LP	13F	Company	0.01%	4,870	$210,000	—	31 Mar 2021	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.01%	4,735	$204,000	—	31 Mar 2021	13F
Old Well Partners, LLC	13F	Company	0.01%	4,683	$202,000	—	31 Mar 2021	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0.01%	4,036	$173,952	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	3,559	$153,000	—	31 Mar 2021	13F
STRS OHIO	13F	Company	0%	2,700	$116,000	—	31 Mar 2021	13F
Legal & General Group Plc	13F	Company	0%	1,176	$51,000	—	31 Mar 2021	13F
ROYAL BANK OF CANADA	13F	Company	0%	1,078	$46,000	—	31 Mar 2021	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	928	$40,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	0%	756	$33,000	—	31 Mar 2021	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	429	$18,000	—	31 Mar 2021	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	351	$12,000	—	31 Mar 2021	13F
Private Capital Group, LLC	13F	Company	0%	34	$1,000	—	31 Mar 2021	13F

Institutional Holders of VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) as of Q2 2021

As of 30 Jun 2021, VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,740,152 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, FMR LLC, Woodline Partners LP, Johnson & Johnson Innovation - JJDC, Inc., VANGUARD GROUP INC, ORBIMED ADVISORS LLC, BlackRock Inc., Sarissa Capital Management LP, and Laurion Capital Management LP. This page lists 49 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.